Back to search
FDAFDA · Food and drugs·Recall number D-399-2013

Phosphatidylcholine and Sodium Deoxycholate Injection, all strengths and all presentations including Phospha_Deoxy-35-30-50 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV 89014.

Published May 22, 2013 · Recall initiated: April 10, 2013

Summary

FDA records drug Class II recall D-399-2013, published May 22, 2013 and initiated April 10, 2013. Recalling firm: FVS Holdings, Inc. dba. Green Valley Drugs; Status: Terminated; Reported quantity: 40 vials; Lot: Lot #: 201303071500JN, Exp 6/7/2013; 1301231000AE, Exp 4/23/2013. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes..

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
FVS Holdings, Inc. dba. Green Valley Drugs
Distributor
Nationwide
Lot
Lot #: 201303071500JN, Exp 6/7/2013; 1301231000AE, Exp 4/23/2013
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Phosphatidylcholine and Sodium Deoxycholate Injection, all strengths and all presentations including Phospha_Deoxy-35-30-50 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV 89014. recalled?

Yes. FDA published recall D-399-2013 on May 22, 2013. Reported hazard: Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes..

What should I do if I have this product?

Voluntary: Firm initiated · Press Release